Cargando…
Association of N6AMT1 rs2254638 Polymorphism With Clopidogrel Response in Chinese Patients With Coronary Artery Disease
Dual antiplatelet treatment with aspirin and clopidogrel is the standard therapy for patients undergoing percutaneous coronary intervention (PCI). However, a portion of patients suffer from clopidogrel resistance (CR) and consequently with recurrence of cardiovascular events. Genetic factors such as...
Autores principales: | Li, He, Zhang, Yan-Jiao, Li, Mu-Peng, Hu, Xiao-Lei, Song, Pei-Yuan, Peng, Li-Ming, Ma, Qi-Lin, Tang, Jie, Zhang, Wei, Chen, Xiao-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156268/ https://www.ncbi.nlm.nih.gov/pubmed/30283338 http://dx.doi.org/10.3389/fphar.2018.01039 |
Ejemplares similares
-
Association of ABCC2 polymorphism with clopidogrel response in Chinese patients undergoing percutaneous coronary intervention
por: Chen, Lida, et al.
Publicado: (2022) -
CD80 DNA methylation and single-nucleotide polymorphism associated with clopidogrel response: a whole-genome DNA methylation analysis in acute coronary syndrome
por: Song, Pei-Yuan, et al.
Publicado: (2023) -
Basigin rs8259 Polymorphism Confers Decreased Risk of Chronic Heart Failure in a Chinese Population
por: Li, Mu-Peng, et al.
Publicado: (2017) -
Development and Validation of a Novel Tool for the Prediction of Clopidogrel Response in Chinese Acute Coronary Syndrome Patients: The GeneFA Score
por: Wu, Hongyi, et al.
Publicado: (2022) -
Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives
por: Zhang, Yan-Jiao, et al.
Publicado: (2017)